Biosurface Engineering Technologies, Inc.
Records under this name other than patents Biosurface Engineering Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Biosurface Engineering Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,671,012 | Formulations and methods for delivery of growth factor analogs Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,246,499 | Composition and Method for Delivery of BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis Formerly held In force · Low confidence | In force | Low confidence | |
| US 7,482,427 | Positive Modulator of Bone Morphogenic PROTEIN-2 Formerly held Term ended Term ended May 31, 2023 · Medium confidence | Term ended | Term ended May 31, 2023 | Medium confidence |
| US 7,981,862 | Composition Comprising BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis Formerly held Term ended Term ended May 31, 2023 · High confidence | Term ended | Term ended May 31, 2023 | High confidence |
| US 8,227,411 | FGF Growth Factor Analogs Formerly held Term ended Term ended Jan 10, 2023 · Medium confidence | Term ended | Term ended Jan 10, 2023 | Medium confidence |
| US 6,765,069 | Plasma cross-linked hydrophilic coating Term ended Term ended Jan 1, 2023 · From the USPTO record | Term ended | Term ended Jan 1, 2023 | From the USPTO record |
| US 9,670,258 | Positive modulator of bone morphogenic protein-2 Formerly held Term ended Term ended Aug 20, 2022 · From the USPTO record | Term ended | Term ended Aug 20, 2022 | From the USPTO record |
| US 10,174,088 | Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis Formerly held Term ended Ended no later than Aug 20, 2022 · From the USPTO record | Term ended | Ended no later than Aug 20, 2022 | From the USPTO record |
| US 10,611,810 | Positive modulator of bone morphogenic protein-2 Formerly held Term ended Ended no later than Aug 20, 2022 · From the USPTO record | Term ended | Ended no later than Aug 20, 2022 | From the USPTO record |
| US 11,078,244 | Composition and method for delivery of BMP-2 amplifler/co-activator for enhancement of osteogenesis Formerly held Term ended Term ended Aug 20, 2022 · From the USPTO record | Term ended | Term ended Aug 20, 2022 | From the USPTO record |